Timothy Hoey, Chief Scientific Officer at Tenaya Therapeutics, Inc. (TNYA), sold 3,300 shares at $7.00 ($23K) on 2024-03-05, disclosed to the SEC on 2024-03-06.
Scheduled sale ($23k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TNYA | SELL | 2023-08-29 | $31K | — | Filing → |
| TNYA | SELL | 2023-08-18 | $15K | — | Filing → |
| TNYA | SELL | 2022-04-28 | $14K | — | Filing → |